Aprea Therapeutics, Inc. (APRE)
0.849
-0.08
(-8.72%)
USD |
NASDAQ |
May 18, 15:59
Aprea Therapeutics Shareholders Equity (Quarterly) : 42.82M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| United Therapeutics Corp. | 5.901B |
| Ernexa Therapeutics, Inc. | 6.859M |
| Recursion Pharmaceuticals, Inc. | 1.025B |
| Tango Therapeutics, Inc. | 391.51M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.11M |
| Total Liabilities (Quarterly) | 5.297M |
| Current Ratio | 8.920 |